Detalhe da pesquisa
1.
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
Lancet Oncol
; 21(3): 398-411, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32014119
2.
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 19(4): 562-578, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29611518
3.
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.
J Clin Oncol
; : JCO2301326, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547438
4.
Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer.
J Clin Oncol
; 39(6): 631-641, 2021 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33439695
5.
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
N Engl J Med
; 355(1): 11-20, 2006 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-16822992
6.
Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
World J Gastroenterol
; 19(48): 9282-93, 2013 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24409055